Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
ConclusionsEvidence on use of anti-IL-1 drugs in DIRA and DITRA is scarce and based on observational studies. Larger studies with better methodological quality are needed to increase confidence in use of these drugs in patients with DIRA and DITRA.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research